Real-world comparison between neoadjuvant FLOT therapy and DCF therapy for resectable esophagogastric junction adenocarcinoma
Authors
- Daisuke Kurita (ORCID: https://orcid.org/0000-0002-4243-3969)
- Yasuyuki Seto
- Junya Oguma (ORCID: https://orcid.org/0000-0002-3865-0514)
- Hiroshi Imazeki
- Hiroshi Igaki (ORCID: https://orcid.org/0000-0001-7817-624X)
- Kazuki Yokoyama
- Yoshitaka Honma (ORCID: https://orcid.org/0000-0002-4209-4493)
- Shun Yamamoto (ORCID: https://orcid.org/0000-0002-9065-781X)
- Taiki Hashimoto (ORCID: https://orcid.org/0000-0003-3148-9243)
- Ken Kato (ORCID: https://orcid.org/0000-0002-1733-5072)
- Hiroyuki Daiko (ORCID: https://orcid.org/0000-0002-9562-2966)
- Tairo Kashihara (ORCID: https://orcid.org/0000-0002-2471-605X)
- Koshiro Ishiyama
- Toshiharu Hirose (ORCID: https://orcid.org/0009-0002-3623-6691)
- Kazuhiro Shiraishi (ORCID: https://orcid.org/0009-0004-3131-1829)
Institutions
- National Cancer Center (US)
- National Cancer Center Hospital East (JP)
- Tokyo National Hospital (JP)